Axsome Therapeutics Inc’s recent filing unveils that its Director Saad Mark E unloaded Company’s shares for reported $1.01 million on Sep 11 ’24. In the deal valued at $91.31 per share,11,016 shares were sold. As a result of this transaction, Saad Mark E now holds 10,002 shares worth roughly $0.85 million.
Then, Saad Mark E bought 11,016 shares, generating $1,005,843 in total proceeds.
Before that, Jacobson Mark L. sold 47,739 shares. Axsome Therapeutics Inc shares valued at $4,022,488 were divested by the Chief Operating Officer at a price of $84.26 per share. As a result of the transaction, Jacobson Mark L. now holds 5,783 shares, worth roughly $0.49 million.
Mizuho reiterated its Axsome Therapeutics Inc [AXSM] rating to an Outperform in a research note published on December 31, 2024; the price target was $122. A number of analysts have revised their coverage, including Wells Fargo’s analysts, who began to cover the stock in early September with a ‘”an Overweight”‘ rating. BofA Securities also remained covering AXSM and has increased its forecast on August 06, 2024 with a “Buy” recommendation from previously “Neutral” rating. Needham started covering the stock on July 22, 2024. It rated AXSM as “a Buy”.
Price Performance Review of AXSM
On Tuesday, Axsome Therapeutics Inc [NASDAQ:AXSM] saw its stock fall -5.23% to $84.60. Over the last five days, the stock has lost -0.62%. Axsome Therapeutics Inc shares have fallen nearly -0.01% since the year began. Nevertheless, the stocks have fallen -2.03% over the past one year. While a 52-week high of $105.00 was reached on 01/02/25, a 52-week low of $64.11 was recorded on 01/10/25. SMA at 50 days reached $92.13, while 200 days put it at $84.48.
Levels Of Support And Resistance For AXSM Stock
The 24-hour chart illustrates a support level at 82.75, which if violated will result in even more drops to 80.90. On the upside, there is a resistance level at 88.24. A further resistance level may holdings at 91.88. The Relative Strength Index (RSI) on the 14-day chart is 43.66, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.87, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 38.73%. Stochastics %K at 54.97% indicates the stock is a holding.
How much short interest is there in Axsome Therapeutics Inc?
A steep rise in short interest was recorded in Axsome Therapeutics Inc stocks on 2024-12-31, dropping by -0.46 million shares to a total of 6.62 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-29 was 7.08 million shares. There was a decline of -6.9%, which implies that there is a negative sentiment for the stock.
